Related Experiment Video
Updated: May 19, 2026

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
Hypertensive goals in patients with coronary artery disease
Ryan T Cunnane1, George L Bakris
1ASH Comprehensive Hypertension Center, The University of Chicago Medicine, IL 60637, USA.
Insights
Lowering blood pressure below 140/90 mm Hg reduces cardiovascular risk, but further reduction below 130/80 mm Hg shows minimal benefit. New guidelines support a target of <140/90 mm Hg.
Area of Science:
- Cardiology
- Clinical Trials
- Hypertension Research
Background:
- Numerous clinical trials have investigated cardiovascular outcomes over the past 20 years.
- Recent trials (last 5 years) demonstrate significant cardiovascular risk reduction with blood pressure below 140/90 mm Hg.
Purpose of the Study:
- To analyze current evidence on optimal blood pressure targets for cardiovascular risk reduction.
- To evaluate the impact of improved standard of care on antihypertensive drug efficacy in recent trials.
Main Methods:
- Review of prospective clinical trials examining cardiovascular outcomes.
- Analysis of data from trials completed within the last 5 and 10 years.
Main Results:
- Blood pressure lowering to <140/90 mm Hg reduces overall cardiovascular risk.
- Driving blood pressure below 130/80 mm Hg does not yield greater risk reduction, with few exceptions like stroke prevention.
- Recent trials show lower baseline cardiovascular risk due to improved standard of care, affecting observed drug efficacy.
- Caution is advised against lowering diastolic blood pressure below 60 mm Hg, particularly in the elderly, to prevent reduced coronary perfusion.
Conclusions:
- Current data support a blood pressure goal of <140/90 mm Hg.
- The efficacy of antihypertensive drug classes may appear reduced in recent trials due to a higher standard of care at baseline.
- Avoiding excessively low diastolic blood pressure is crucial for maintaining coronary perfusion, especially in elderly populations.
Abstract:
There are many prospective clinical trials that have examined cardiovascular outcomes over the past 2 decades. Trials completed within the last 5 years clearly indicate that overall cardiovascular risk is reduced by blood pressure lowering to levels below 140/90 mm Hg. Greater cardiovascular risk reduction is not seen, however, by driving blood pressure to levels well below 130/80 mm Hg. This is true across the spectrum of cardio-renal risk with few exceptions, stroke prevention possibly being one. Further there should be an awareness that outcome studies performed within the last decade will not have the same risk reduction of a given class of antihypertensive drug previously tested. This is primarily due to an improved standard of care that was not present in trials of a decade ago and thus, more recent trials have lower cardiovascular risk at baseline. Lastly, new guidelines will most likely change the goal blood pressure to <140/90 mm Hg as all data support this level. Lastly, the caution of lowering diastolic blood pressure below 60 mm Hg especially in the elderly must be avoided to minimize reductions in coronary perfusion.
Related Concept Videos
Hypertension V: Nursing Management
Coronary Artery Disease IV: Preventive Measures
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension and Regulation of Blood Pressure